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 
Abstract—Metabolites are the ultimate readout of disease 
phenotype that play a significant role in the study of human 
disease. Multiple metabolites sometimes serve as biomarkers for a 
single metabolic disease. Therefore, simultaneous detection and 
analysis of those metabolites facilitates early diagnostics of the 
disease. Conventional approaches to detect and quantify 
metabolites include mass spectrometry and nuclear magnetic 
resonance that require bulky and expensive equipment. Here we 
present a disposable sensing platform that is based on 
complementary metal oxide semiconductor process. It contains 
two sensors: an ion sensitive field effect transistor and photodiode 
that can work independently for detection of pH and colour 
change produced during the metabolite-enzyme reaction. Serum 
glucose and cholesterol have been detected and quantified 
simultaneously with the new platform, which shows good 
sensitivity within the physiological range. Low cost and easy 
manipulation make our device a prime candidate for personal 
metabolome sensing diagnostics. 
 
Index Terms—Simultaneous detection, CMOS-based sensor 
system, coronary heart disease, serum metabolites, personal 
diagnostics  
 
I. INTRODUCTION 
ECENTLY, metabolomics studies have been proven to 
provide novel insights into biomarker discovery.[1-3] 
Metabolism is a vital cellular process, and metabolic 
dysfunction can be a major contributor to many human 
diseases.[4] Metabolites are the ultimate readout of disease 
phenotype, which can serve as a metabolic disease biomarker, 
therefore quantification and analysis of metabolites plays a 
significant role in the study of biochemical reaction and 
signaling networks. [4, 5]  
One metabolite can be biomarker for different diseases but 
multiple metabolites can serve together as a biomarker for one 
disease. Neurodegenerative diseases such as Huntington’s 
disease,[6-8] cardiac disease includes ischemic stroke,[2, 9] and 
many cancers[4, 10] all have numerous metabolite biomarkers.  
Mass spectrometry (MS) is the most commonly used 
analytical technique to detect and quantify metabolites.[11, 12] 
It ionizes chemical species and sorts the ions based on the mass-
to-charge ratio. Separation methods such as gas 
chromatography (GC) [13, 14] and liquid chromatography (LC) 
[15, 16] are usually required prior to the mass analysis. Nuclear 
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magnetic resonance (NMR) spectroscopy is another technique 
that has been applied to metabolite studies.[17-20] It is a 
powerful tool for detecting, identifying and quantifying a wide 
range of metabolites without separation. However, both 
methods require bulky and expensive equipment. For 
widespread uptake of metabolite sensing in Point of Care (PoC) 
settings, the biosensor needs to be small, disposable and hence 
low cost.  
The ion sensitive field effect transistor (ISFET) [21-24] and 
photodiode (non-UV) [25] have recently been proven to be 
novel and low-cost sensors for metabolite studies. An ISFET is 
a field-effect transistor that uses a solution as the gate electrode. 
It measures ion concentrations (e.g. H+) in solution and when 
the ion concentration changes, the current through the transistor 
changes accordingly.[26] Numerous metabolites (e.g. urea, 
acetylcholine, and glucose) produce H+ ions when they interact 
with specific enzymes, therefore the concentration of 
metabolites can be detected according to the H+ ion generated. 
A photodiode (PD) is a semiconductor device that absorbs light 
energy (photons) to generate a photo-current. If a PD is 
immersed in a liquid, the colour of which changes in the course 
of a reaction, then a change in the transmission of light through 
the liquid can be detected. If the light is chosen to be a 
wavelength that is strongly absorbed as the liquid changes 
colour, then quantification becomes possible. H2O2 is a 
common product generated during metabolite-enzyme reaction. 
When combined with a peroxidase and a redox colour-change 
indicator, the evolution of H2O2 is a reaction can then be 
detected by a PD. The concentration of metabolite relies on the 
absorption of the photons. 
ISFET and photodiode can be fabricated at low cost for 
portable devices, providing an opportunity to make PoC 
platforms for metabolomics applications. Previous work has 
shown that both ISFETs and PDs can be used to detect single 
metabolites. Dual or multiple measurement might have been 
done but only on sole ISFET [27] or PD [28]. 
Here we report a more flexible approach for the detection of 
two metabolites in human serum simultaneously using a low-
cost complementary metal-oxide-semiconductor (CMOS)-
based device contains ISFET and PD. The ISFET and PD are 
able to work independently and simultaneously in the same 
solution. The ISFET and PD are fabricated using a standard 
commercial 350 nm CMOS process. Mass production reduces 
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2 
the cost for a single chip so as to make it suitable for PoC 
applications.  
Serum glucose is a vital fuel source in the human body. 
However elevated blood glucose can be a sign of 
hyperglycaemia or diabetes and may cause coronary heart 
disease. Serum cholesterol performs many essential duties in 
human body. It serves as a precursor for the biosynthesis of 
steroid hormones, bile acid and Vitamin D.[29] Higher levels 
of total cholesterol increase the risk of cardiovascular disease, 
particularly coronary heart disease. Both serum glucose and 
cholesterol have been comprehensively studied and proven to 
be independent risk factors for coronary heart disease.[30, 31] 
H. W. Cohen et al.,[32] in 2004 discovered that there is an 
adverse synergistic interaction of fasting glucose with total 
cholesterol that magnifies the risk of incident coronary heart 
disease events associated with total cholesterol for hypertensive 
patients. Therefore serum glucose and cholesterol were chosen 
as the metabolites to be measured with our device. The glucose-
hexokinase reaction produces protons and cholesterol- 
cholesterol oxidase reaction generates H2O2. Protons can be 
detected by ISFET and H2O2 can be measured by PD with the 
addition of redox indicator. Simultaneous detection of glucose 
and cholesterol from human serum was successfully performed 
with our CMOS-based device contains ISFET and PD. Since 
the two sensors work independently of each other, are detecting 
photons (PD) and protons (ISFET), we observe neither 
chemical nor electrical cross-talk in our device. This makes it 
suitable for detection of any other metabolites simultaneously, 
providing a cost-effective method for early diagnostic of 
disease. 
II. MATERIALS AND METHODS 
A. Device fabrication and structure 
The chip was designed to incorporate a 16 x 16 array of 
sensor clusters with each cluster integrating a PD “pixel” and 
an ISFET “pixel” to enable simultaneous optical and ionic 
detection on the same surface. Each PD pixel integrates a pn-
junction with a classic 3-transistor readout design. A global 
shutter scheme employing an integrated 4-bit row decoder and 
a 4-bit column decoder was used to scan through the PD array. 
The ISFET sensor was designed using a source follower 
configuration of two p-type transistors in which one gate is kept 
floating using a stack of three metals and exposed layer of 
silicon dioxide (SiO2). This layer was realized by removing the 
two top passivation layers (polyamide and silicon nitride 
(Si3N4)) as illustrated in Fig. 1a. The ISFET array was scanned 
using two integrated decoders of 4-bits and 3-bits each, for 
addressing the columns and rows via an 8 to 1 analogue 
multiplexer outside the array active area. The entire ISFET 
array was designed using isolated transistors in deep n-wells to 
minimize crosstalk with the PD array. The chip (Fig. 1b) was 
fabricated using a commercially available CMOS 350 nm high 
voltage 4-metal process provided by austriamicrosystems. It is 
a ‘twin-tub’ process that gives good electrical isolation. A 
printed circuit board (PCB) platform was designed to interface 
the chip with an ARM mbed STM32 Nucleo-F334R8 board 
(STMicroelectronics, UK). The mbed microcontroller was 
programmed to provide addressing signals and to acquire the 
output readings from both PD and ISFET array outputs. The 
acquired data was then transferred by universal serial bus 
(USB) to a computer LabVIEW program, where it was 
processed and analyzed. 
 
Fig. 1.  (a) Schematic diagram of one sensor cluster showing the internal 
structure of ISFET and PD (not to scale). (b) Microscope image of one CMOS 
chip, containing 256 individual sensor clusters (16×16). Insert is the enlarged 
view of a single sensor cluster, which is comprised by one ISFET and one PD 
sensor. 
  
B. Measurement configuration 
For packaging, the chip was glued to a chip carrier and wire 
bonded. Biocompatible epoxy was then applied to open a 
sensing window on top of the chip and at the same time protect 
the bondwires from touching the analyte solution as illustrated 
in Figure 2. A custom-made plastic square base was glued onto 
the chip carrier, which was fitted with a custom-made 
rectangular cylinder. The cylinder functioned as a lid with 
integrated green LED (502 nm) and Ag/AgCl reference 
electrode. The green LED provided the light source for the PD 
and the reference electrode provided liquid gate voltage for the 
ISFET respectively. A sealed, dark and well-controlled 
environment for the measurement was created by the cylinder 
cap. A flexible heater was attached to the back of the chip 
carrier and its temperature was controlled by a PID temperature 
controller through a thermocouple. In this way, the sensor could 
be kept at a constant temperature of 37 °C, which is necessary 
for the best results to be obtained using some enzyme-based 
reactions. 
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3 
Prior to each measurement, the entire sensing well was 
incubated with 3% bovine serum albumin (BSA) in 5 mM 
Triethanolamine buffer (see chemical preparation) for 30 
minutes. It prevents molecules from attaching to the chip 
surface so as to minimize nonspecific binding. 10 µl silicone oil 
was then applied to prevent the buffer from evaporating. The 
reaction buffer (see chemical preparation) that contains all the 
enzymes and chemicals required for the reactions except the 
metabolites was then added to the sensing well to form a 
baseline signal. After 2 to 3 minutes, 10 µl 138 mg/dl human 
serum was added to initiate the two reactions: glucose-
hexokinase and cholesterol-cholesterol oxidase. The former 
reaction produces protons which are detected by the ISFET and 
the latter generates colour change which is sensed by the PD 
(Fig. 2b). 
 
Fig. 2.  Schematic diagram of the measurement configuration. (a) All the 
components for the two enzyme reactions are mixed and added to the sensing 
window. (b) Reactions are initiated by applying the analyte. pH and colour 
change are sensed by ISFET and PD simultaneously. 
 
 
C. Chemical preparation 
Triethanolamine hydrochloride (T9534), taurocholic acid 
sodium salt hydrate (T4009), sodium cholate hydrate (C1254), 
o-Dianisidine dihydrochloride (F5803), Adenosine 5′-
triphosphate (ATP) disodium salt hydrate (A2383), Triton X-
100 (T9284), silicone oil (85409), glucose (G8270), cholesterol 
(C3045), peroxidase from horseradish (P8250), cholesterol 
esterase from pseudomonas fluorescens (C9281), hexokinase 
from saccharomyces cerevisiae (H4502), cholesterol oxidase 
from streptomyces sp (C8649), and human serum from human 
male AB plasma USA origin sterile-filtered (H4522) are 
purchased from Sigma Aldrich. Bovine serum albumin (BSA) 
(11413164) is purchased from Fisherscientific. Sodium 
chloride (VWR27810), Magnesium chloride hexahydrate 
(VWR25108), Sodium hydroxide pellets (0583) from VMR. 
Triethanolamine buffer was prepared by adding 5 mM 
triethanolamine hydrochloride to 50 mM sodium chloride 
solution. 1 M Sodium hydroxide solution was then used to 
adjust the pH of the buffer to 8. o-Dianisidine solution was 
prepared with deionized water saturated in oxygen and kept in 
dark. o-Dianisidine was chosen because it is a pH independent 
redox indicator, which is not affected by the pH drop generated 
from the glucose-hexokinase reaction. Cholesterol solution was 
prepared and diluted with triton X-100 and Triethanolamine 
buffer under heating at 70 °C. Glucose solution was prepared 
and diluted with Triethanolamine buffer. The ATP solution was 
prepared with Triethanolamine buffer. All the enzymes were 
prepared and diluted with Triethanolamine buffer.  
The reaction buffer was prepared by mixing together the 
following enzymes and chemicals which are required for 
simultaneous glucose and cholesterol detection measurements: 
46.9 µl 5mM triethanolamine HCl at pH 8, 1.7 µl 15% w/w 
taurocholic acid solution, 1.7 µl 15% w/w cholic acid solution, 
5 µl 60U/ml peroxidase, 10 µl 500 mM NaCl, 1.7 µl 8.5 U/ml 
cholesterol esterase, 10 µl 100 mM MgCl2 solution, 10 µl 100 
mM ATP pH8.5, 4 µl 7.89 mM o-Dianisidine, 1 µl 0.1 U/µl 
hexokinase, and 3 µl 10 U/ml cholesterol oxidase.  
 
III. RESULTS AND DISCUSSIONS 
A. Characteristics of the ISFET and PD 
Prior to the actual simultaneous detection measurement with 
real analyte, the device was required to be characterized. The 
pH sensitivity of the CMOS based ISFET and the response (to 
the colour change) of the PD needed to be verified. The ISFET 
was characterized with Triethanolamine buffer that has the 
same salt concentration and buffering capacity as the actual 
measurement. Four different buffers with pH values 6, 7, 8 and 
9 were made via adding 1M HCl or 1M NaOH. Prior to each 
measurement, the entire sensing well was incubated in 3% 
bovine serum albumin (BSA) in PBS to minimize nonspecific 
binding. After washing the chip thoroughly with deionized 
water, 100 µl pH 9 buffer was firstly added to the sensing well 
to obtain a baseline signal. The buffer was then replaced by pH 
8, 7, and 6 buffer sequentially, which covered the pH range 
expected in actual measurements. Clear steps were observed 
between the buffers with different pH value (Fig. 3a). ΔVISFET 
is a linear function of pH with a slope of ∼35 mV/pH, which is 
in line with literature values for SiO2 surfaces in the linear 
region.[33] 
The PD was characterized with hydrogen peroxide (H2O2), 
which is a common product generated during the metabolite-
enzyme interaction. Five different concentrations of H2O2 from 
31 µM to 375 µM were measured (Fig. 3b). The H2O2 solution 
was prepared and diluted with Triethanolamine buffer at pH 8. 
A mixed solution of o-Dianisidine (7.89 mM) and peroxidase 
(60 U/ml) was first added to the sensing well to get a baseline 
signal. The H2O2 solution was then added to trigger the reaction 
and the colour change was then detected by the PD. A linear 
function of PD voltage vs H2O2 concentration (from 31 µM to 
375 µM) was observed.  
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Fig. 3.  Characteristics of the ISFET and photodiode. (a) An ISFET is 
characterized with Triethanolamine buffer that has four different pH values 
from 9 to 6. The voltage is a linear function of pH with a sub-Nernstian slope 
of 35 mV/pH (insert). (b) A PD is characterized with H2O2 solution, which is a 
common product generated during the metabolite-enzyme interaction. A linear 
function of PD voltage vs H2O2 concentration is plotted out from the result as 
inserted. 
  
Both the ISFET and PD had been characterized using an 
appropriate solution and method. The characterization result 
demonstrates that they are sufficiently sensitive for the actual 
metabolite detection measurement. 
 
B. Chemical multiplexing and cross-talk 
Two metabolite-enzyme interactions (chemical equation 1, 2, 
3, 4) are carried out in one sensing well, therefore the 
optimization of measurement condition is important. It is well 
known that pH, ionic strength and temperature are crucial for 
the stability and activity of enzyme reactions.[34-36] Those 
three aspects were investigated independently.  
The first condition that was checked is pH. According to the 
manufacturer, triethanolamine hydrochloride is useful in the 
range of 7.3 to 8.3. Cholesterol oxidase from streptomyces sp. 
is stable from pH 5 to 10 and optimum from 6.5 to 7. 
Hexokinase from saccharomyces cerevisiae is optimal from 7.5 
to 9. Peroxidase from horseradish is stable in the range of 5 to 
9 and optimal from 6 to 6.5. The interaction from glucose-
hexokinase decreases pH by a value of around 1, therefore three 
pH values (7.5, 8 and 8.5) were investigated (Fig. 4). It turned 
out that 8 is the best pH value for the buffer which gives the 
best performance for both metabolite-enzyme interactions.  
 
Fig. 4.  Comparison of the reaction rates with different pH buffers. The glucose-
hexokinase and cholesterol-cholesterol oxidase measurements were undertaken 
with buffers that have different pH values (7.5, 8 and 8.5). The reaction rates 
that extracted from the measurements with pH 8 buffer are the best for both 
reactions. 
 
Ionic strength not only plays an important role in enzyme-
based reaction, but also affects the performance of the ISFET. 
50 mM was found to be an appropriate salt concentration for 
both requirements. In addition, buffering capacity is another 
aspect that matters for the measurement especially for the 
ISFET. When using an ISFET to detect pH change, low 
buffering capacity is required, because small pH variation can 
be screened if the buffering capacity is too high. 5 mM buffer 
was finally used, which is sufficient for maintaining the 
stability of the buffer as well as allowing the detection of small 
pH changes. It was unknown that if the buffering capacity was 
an issue for the metabolite-enzyme interaction or not. A 
comparison was done among the cholesterol-cholesterol 
oxidase measurements on PD with 5 mM, 50 mM and 500 mM 
buffer respectively. The result indicates that buffering capacity 
does not show obvious impact on the enzyme reaction 
performance.  
 
Fig. 5.  Temperature effect on the performance of ISFET and PD. The pH 
sensitivity of the CMOS based ISFET and the response (to the colour change) 
of the PD were investigated at 37 °C. (a) An ISFET sensor was characterized 
with Triethanolamine buffer with pH values of 6, 7, 8 and 9. Compared to the 
room temperature (RT), 37 °C decreases the pH value of the buffer as expected 
so as to increase the ISFET voltage value, but the sensitivity (slope of the curve) 
stays the same. (b) A photodiode sensor was characterized with hydrogen 
peroxide (H2O2), and five different concentration of H2O2 from 31 µM to 375 
µM were measured. No obvious difference is observed between the two 
temperatures. 
 
As previously discussed, experiments were carried out at 37 
°C to aid optimization of enzyme performance. Like most 
chemical reactions, the rate of an enzyme-catalyzed reaction 
increases as the temperature is raised. The optimal temperature 
is usually around human body temperature (37 °C) for the 
enzymes in human cells.[37] To obtain free cholesterol from 
cholesterol esters in serum, 37 °C is also required. Therefore the 
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5 
temperature was set to 37 °C throughout all the measurements. 
ISFET and PD are normally operated under room temperature. 
Therefore, we compared the experimental results at room 
temperature and at 37 °C to determine whether there is a 
significant difference (Fig. 5). 
 
𝐷 − 𝐺𝑙𝑢𝑐𝑜𝑠𝑒 + 𝐴𝑇𝑃
𝐻𝑒𝑥𝑜𝑘𝑖𝑛𝑎𝑠𝑒
→         𝐷 − 𝐺𝑙𝑢𝑐𝑜𝑠𝑒 − 6 − 𝑃 + 𝐴𝐷𝑃 +𝐻+    (1) 
 
 
𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 𝐸𝑠𝑡𝑒𝑟𝑠 + 𝐻2𝑂
𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 𝐸𝑠𝑡𝑒𝑟𝑎𝑠𝑒
→                                                                          
                                                                    𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 +  𝑂𝑙𝑒𝑖𝑐 𝐴𝑐𝑖𝑑            (2) 
 
𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 + 𝑂2
𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 𝑂𝑥𝑖𝑑𝑎𝑠𝑒
→                                                                                            
                                                        4 − 𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑛 − 3 − 𝑜𝑛𝑒 + 𝐻2𝑂2           (3) 
 
𝐻2𝑂2 + 𝑜 − 𝐷𝑖𝑎𝑛𝑖𝑠𝑖𝑑𝑖𝑛𝑒 (𝑟𝑒𝑑𝑢𝑐𝑒𝑑)
𝑃𝑒𝑟𝑜𝑥𝑖𝑑𝑎𝑠𝑒
→                                                                
                                                     𝐻2𝑂 + 𝑜 − 𝐷𝑖𝑎𝑛𝑖𝑠𝑖𝑑𝑖𝑛𝑒 (𝑂𝑥𝑖𝑑𝑖𝑧𝑒𝑑)         (4)     
                                                                                  
Cross-talk is a common issue along with simultaneous 
detection in both electrical and optical measurements. In our 
study, two metabolite-enzyme interactions were carried out in 
one sensing window. Different enzymes and chemicals required 
for those two measurements were mixed together. In addition, 
an LED (502nm; LUMEX) and an Ag/AgCl reference electrode 
were utilized for the measurement. The LED was used as light 
source for the PD and the reference electrode was inserted to 
provide gate voltage for the ISFET.  
 
 
Fig. 6.  Measurements for the investigation on cross-talk. (a) The glucose-hexokinase reaction was performed on the PD. Compared to the buffer-buffer test, no 
obvious difference is observed, indicating that the pH change associated with the glucose-hexokinase reaction does not affect the performance of the PD. The spike 
at t = 200 s arises as a consequence of disturbing the device when reagents are added; (b) The cholesterol-cholesterol oxidase reactions were undertaken on the PD 
with and without the presence of glucose-hexokinase reaction. No obvious difference is seen between them, which means that the glucose-hexokinase reaction has 
no impact on the cholesterol-cholesterol oxidase reaction when using the PD for detection; (c) The cholesterol-cholesterol oxidase reaction was performed on the 
ISFET. Compared to the buffer-buffer test, no obvious difference is observed, indicating that the reaction does not affect the performance of the ISFET; (d) The 
glucose-hexokinase reactions were undertaken on the ISFET with and without the presence of cholesterol-cholesterol oxidase reaction. No obvious difference is 
seen between them, which implies that the cholesterol-cholesterol oxidase reaction has no impact on the glucose-hexokinase reaction when the ISFET is used for 
the measurement. 
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Ideally the two measurements would work independently of 
each other. For example, the glucose-hexokinase assay that 
produces pH change would have no effect on either the PD or 
the cholesterol-cholesterol oxidase interaction and the 
cholesterol-cholesterol oxidase assay that generate colour 
change would have no effect on either the ISFET or the glucose-
hexokinase interaction. In order to evaluate the degree of cross-
talk. If any, we carried out the following experiments (Fig. 6): 
glucose-hexokinase assay over the PD; cholesterol-cholesterol 
oxidase assay over the ISFET; cholesterol-cholesterol oxidase 
assay with and without the presence of glucose-hexokinase 
interaction over the PD; and glucose-hexokinase assay with and 
without the presence of cholesterol-cholesterol oxidase 
interaction over the ISFET. The result reveals that the pH drop 
generated from the glucose-hexokinase interaction does 
decrease the reaction rate of cholesterol-cholesterol oxidase 
interaction a little bit but not dramatically enough to affect the 
performance of the assay. Apart from that, no obvious cross-
talk was observed.  
The first measurement carried out was to perform the 
glucose-hexokinase assay on the PD (Fig. 6a). This is to check 
if the pH drop generated by the glucose-hexokinase interaction 
affects the performance of the PD. Only the PD sensor was 
adopted with the LED was switched on. The enzymes and 
chemicals for glucose-hexokinase were first placed on the PD 
to give a baseline signal and then a high concentration (3 mM) 
of glucose solution was added to initiate the reaction. For the 
comparison purpose, a buffer-buffer test was also performed. In 
the buffer-buffer test, Triethanolamine buffer was first placed 
on the PD to give a baseline signal and then the same buffer was 
applied to mimic the experimental procedure of metabolite-
enzyme assay.  
The second measurement was to perform the cholesterol-
cholesterol oxidase assay only on the PD with the presence of 
glucose-hexokinase interaction (Fig. 6b). This is to check if the 
pH drop generated by the glucose-hexokinase reaction or the 
materials themselves affects the cholesterol-cholesterol oxidase 
interaction. Only the PD sensor was adopted with the LED was 
switched on. The enzymes and chemicals for both reactions 
were placed on the PD to give a baseline signal and then a 
solution contains 400 µM cholesterol and 3 mM glucose was 
added and mixed to trigger both reactions. For the comparison 
purpose, a sole cholesterol-cholesterol oxidase assay was also 
performed with 400 µM cholesterol.  
The third measurement was done is to perform the 
cholesterol-cholesterol oxidase reaction on the ISFET (Fig. 6c). 
This is to check if the products generated from the cholesterol-
cholesterol oxidase reaction affects the performance of ISFET. 
Only the ISFET sensor was adopted with the reference 
electrode was inserted and the gate voltage was applied. The 
enzymes and chemicals for cholesterol-cholesterol oxidase 
were first placed on the ISFET to give a baseline signal and then 
a high concentration (800 µM) of cholesterol solution was 
added to initiate the reaction. As a comparison, a buffer-buffer 
test was also performed.  
The fourth measurement performed was the glucose-
hexokinase assay on the ISFET with the presence of 
cholesterol-cholesterol oxidase interaction (Fig. 6d). This is to 
check if the products generated by the cholesterol-cholesterol 
oxidase reaction or the reaction itself affects the glucose-
hexokinase reaction. Only the ISFET sensor was adopted with 
the reference electrode is inserted and the gate voltage is 
applied. The enzymes and chemicals for both reactions were 
placed on the ISFET to give a baseline signal and then a solution 
contains 400 µM glucose and 800 µM cholesterol was added 
and mixed to trigger both reactions. For comparison purposes, 
a sole glucose-hexokinase assay was also performed with 400 
µM glucose.  
As discussed previously, to perform measurement on the 
ISFET, a reference electrode is required and to undertake 
experiment on the PD, LED illumination is essential. Ideally the 
reference electrode would have no effect on the PD and the 
LED would have no effect on the ISFET. To evaluate the effect 
of LED illumination on the performance of the ISFET, a 
stability test was performed on the ISFET with only 
Triethanolamine buffer when the LED is switched on. It turns 
out that the ISFET is not affected by the LED no matter it is on 
or off (Fig. 7a). To check the effect of liquid gate voltage 
applied on the reference electrode on the PD, a stability test with 
Triethanolamine buffer was undertaken on the PD in which the 
electrode was inserted and gate voltage was applied. The result 
shows that the liquid gate voltage does not have any obvious 
impact on the PD (Fig. 7b). 
 
Fig. 7.  The impact of LED and reference electrode on measurements. (a) A 
stability test was performed on the ISFET with only Triethanolamine buffer. 
No obvious change is observed from the process of switching on and off of the 
LED; (b) A stability test was undertaken on the PD with only buffer. No obvious 
change is seen from the action of increasing the gate voltage. 
 
No obvious cross-talk was observed from the above 
measurements. The CMOS based device demonstrates a good 
capability to undertake simultaneous detection of metabolites 
with the ISFET and PD independently. 
 
C. Simultaneous detection of serum glucose and cholesterol 
Serum glucose and cholesterol were measured 
simultaneously with the ISFET and PD. Human serum is 
purchased from Sigma-Aldrich which contains approximately 
3 mM glucose and 4 mM cholesterol. It was then diluted with 
Triethanolamine buffer to give 4 different concentrations (45, 
95, 190, and 375 µM for glucose and 50, 100, 200, and 400 µM 
for cholesterol). In the control measurement, instead of human 
serum sample, the Triethanolamine buffer was used. 
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Fig. 8.  Simultaneous detection of serum glucose and cholesterol. (a) An extracted plot that shows the real time detection result from one high concentration of the 
human serum. The red dashed line indicates when the serum sample was added. The signal changes derived from the glucose-hexokinase and cholesterol-cholesterol 
oxidase interactions were observed and recorded immediately and simultaneously by the ISFET (blue curve) and PD (orange curve). Four concentrations of human 
serum were taken as the analyte for the measurement. (b) ISFET voltage vs time plot extracted from the detection of serum glucose. (c) PD voltage vs time plot 
extracted from the detection of serum cholesterol. 
 
A green LED with a wavelength of 502 nm was chosen 
because it is the optimal wavelength for the PD and oxidized o-
Dianisidine.[25] The gate voltage applied on the reference 
electrode was set to 0V, which stabilizes the liquid potential and 
at the same time does not interfere the enzymatic reaction. The 
reaction buffer which includes all the enzymes and chemicals 
was added to the sensing well to get baselines for both the 
ISFET and PD. The human serum sample was added to initiate 
the reactions. Signal changes occurred immediately and 
simultaneously on both the ISFET and PD (Fig. 8a). The 
metabolite-enzyme interactions were measured through the 
change in voltage as a function of time and the data are shown 
in Figure 4. The reaction buffer was initially added at time 0 
and the voltage was continuously measured. Immediately after 
adding human serum sample to the sensing window at time 
150s, a change of signal in voltage that comes from the reaction 
was observed from both the ISFET and PD at the same time. In 
total 4 concentrations of human serum and one control buffer 
solution were measured. The change in ISFET and PD voltage 
for different concentrations were plotted in the figure and the 
slope of the curve over the first two minutes of the reaction 
(marked by a red dashed square) was used to calculate the 
reaction rate (using Matlab). The figure of initial reaction rate 
and end point voltage (at 1500 second) against metabolite 
concentration was plotted and fitted by using Michaelis-Menten 
equation (Equation 1) as shown in Figure 5. 
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Fig. 9.  Plots of the initial reaction rate vs concentration of metabolites. (a) Plot of the initial reaction rate (determined within the dashed square in Figure 4a) and 
(b) end value vs concentration of serum glucose. (c) Plot of the initial reaction rate (determined within the dashed square in Figure 4b) and (d) end value vs 
concentration of serum cholesterol. The plots were fitted to the Michaelis-Menten equation. Data are the mean ± SEM (three measurements with two devices). 
Insert shows the Lineweaver-Burk plot. The Michaelis constants (Km) were calculated and found to be comparable with the literature. 
 
The Michaelis-Menten equation (equation 1) was also utilized 
to identify the Michaelis constant (Km), which is the substrate 
concentration at which the reaction rate is half of the maximum 
rate that can be achieved. It indicates how effectively a substrate 
interacts with a given enzyme. In addition, the Lineweaver-
Burk plot was also generated (inserted in Fig. 9) to provide a 
graphical method for better understanding and analysis of the 
reaction. The Km values were calculated and found to be 428 ± 
133 µM (reaction rate) and 350 ± 167 µM (end value) for 
glucose-hexokinase and 103 ± 39 µM (reaction rate) and 186 ± 
49 µM (end value) for cholesterol-cholesterol oxidase 
respectively. This can be compared with the literature value of 
150 µM [38] for hexokinase and 96 µM [39] for cholesterol 
oxidase. The Km values determined using a CMOS-based 
device are slightly higher than measured conventionally, this 
may be due to the pH and/or ionic concentration, which are not 
optimized for individual reaction but for the two reactions. 
 
𝑣 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑀+[𝑆]
                                                                       (1)   
 
where v is the reaction rate (current or threshold voltage change 
with time), Vmax is the maximum rate and Km, is the Michaelis 
constant.  
The Limit of Detection (LOD) determined from 3 x standard 
deviation of the blank signal is approximately 18 µM for 
glucose and 6 µM for cholesterol. The high sensitivity makes 
the method presented here is applicable to the detection of many 
other metabolites.  
Hexokinase has the potential to detect sugars other than 
glucose (e.g. fructose). Therefore to demonstrate the selectivity 
of the dual measurement, simultaneous detection of solution 
glucose and cholesterol was performed in the same way as was 
done for human serum (above). The reaction buffer, including 
all the required enzymes and chemicals was firstly added to the 
sensing well to get baselines for both ISFET and PD. Instead of 
adding serum sample, solution glucose and cholesterol mixture 
was used to initiate the two reactions. 3 mM glucose and 800 
µM cholesterol were prepared and mixed with Triethanolamine 
buffer to provide the highest concentration. It was then diluted 
with the same buffer to give in total seven different 
concentrations of them. The Km was found to be 244 ± 21 µM 
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for the glucose and 80 ± 11 µM for the cholesterol. Data are the 
mean ± SEM (three measurements with two devices). The result 
from the solution containing glucose and cholesterol matches 
well with that from the human serum, indicating that among the 
metabolites in the human serum, only the glucose and 
cholesterol were detected selectively by our sensor platform.  
 
D. Data analysis and statistics 
As introduced, the chip was designed to incorporate a 16 x 16 
array of clusters with each cluster integrating a PD “pixel” and 
an ISFET “pixel” to enable simultaneous optical and electrical 
detection on the same surface. Therefore the final result can be 
obtained by averaging the data from the 256 cluster sensors to 
reduce the noise level. In addition, where there are some 
nonfunctional pixels, results can still be acquired from the 
functioning pixels. A custom-written LabVIEW program was 
designed to acquire and average the data. (Fig. 10) 
 
Fig. 10.  Software interface for data analysis. A LabVIEW based program was written for data analysis. It contains six windows (from top left to bottom right): PD 
Single pixel, PD Average, Intensity Graph (PD), ISFET Single pixel, ISFET Average, and Intensity Graph (ISFET). ‘PD Single pixel’ plots the intensity change 
of one PD pixel during the reaction against the time; ‘PD Average’ gives the averaged intensity change from the entire 256 pixels; ‘Intensity Graph (PD)’ shows 
the intensity layout of the 256 PD pixels. The same explanation is applied to the ISFET. As shown in the figure, the signal from a selected single pixel of PD sensor 
is very noisy (PD Single pixel), but after averaging the entire 256 pixels, the signal is dramatically improved (PD Average). 
 
IV. CONCLUSION 
Low cost CMOS-based ISFET and photodiode sensors have 
been fabricated and used to detect and analyze metabolites 
simultaneously via pH and colour changes. An assay for 
simultaneous detection of risk factors for coronary heart disease 
(glucose and cholesterol) in human serum has been developed 
with pH and colorimetric readout. The assay can be performed 
using the CMOS-based device in one single well, unlike 
conventional approaches that require separate samples and 
different detection equipment. No obvious crosstalk was 
observed, indicating that this approach can be easily applied to 
detect other metabolites that produce pH and/or colour change 
during the enzyme reaction. Compared with current analytical 
methods for metabolite detection and quantification, no 
expensive detection equipment is required and the volume of 
the test sample is very small. An important advantage of this 
assay is that two metabolites were analyzed simultaneously in 
one sensing window in real time. This provides useful 
information for monitoring and diagnostic purposes. This 
CMOS-based ISFET and photodiode device shows potential to 
become a rapid point of care diagnostic system. 
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